F. Javier Pérez-Areales

Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies

Ornella Di Pietro, F. Javier Pérez-Areales, Jordi Juárez‐Jiménez et al. · European Journal of Medicinal Chemistry · 2014 · 64 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Design, Synthesis and Multitarget Biological Profiling of Second-Generation Anti-Alzheimer Rhein–Huprine Hybrids

F. Javier Pérez-Areales, Nibal Betari, Antonio Viayna et al. · Future Medicinal Chemistry · 2017 · 51 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties

F. Javier Pérez-Areales, Ornella Di Pietro, Alba Espargaró et al. · Bioorganic & Medicinal Chemistry · 2014 · 42 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis

Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez et al. · Pharmaceuticals · 2022 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors

F. Javier Pérez-Areales, Andreea L. Turcu, Marta Barniol‐Xicota et al. · European Journal of Medicinal Chemistry · 2019 · 38 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +14